Description

Wegovy (Semaglutide) Weight Loss Shots

It is also approved for adults who are overweight with at least one weight-related medical condition. When combined with a reduced-calorie diet and increased physical activity, Wegovy helps reduce excess body weight and supports long-term weight management. It also has approved uses for reducing cardiovascular risk in certain patients.

How Wegovy Works

Wegovy contains semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist that mimics a naturally occurring hormone involved in appetite regulation. It works by:

• Reducing hunger and food cravings
• Increasing feelings of fullness after meals
• Slowing stomach emptying
• Helping reduce daily calorie intake
• Supporting sustainable weight loss when combined with healthy lifestyle changes

Key Benefits

• FDA-approved for chronic weight management
• Convenient once-weekly injection
• Helps reduce appetite and calorie intake
• Clinically proven to support significant, sustained weight loss when combined with diet and exercise
• Helps maintain long-term weight reduction
• Approved to reduce the risk of major cardiovascular events in certain adults with established cardiovascular disease and obesity or overweight (FDA Access Data)

Who May Be Eligible?

Wegovy may be prescribed for:

• Adults with a Body Mass Index (BMI) of 30 kg/m² or greater (obesity), or
• Adults with a BMI of 27 kg/m² or greater (overweight) who have at least one weight-related condition, such as:
  • High blood pressure
  • Type 2 diabetes
  • High cholesterol
• Adolescents aged 12 years and older with obesity who meet the prescribing criteria.

Treatment should always be prescribed and monitored by a licensed healthcare provider.

Common Side Effects

The most common side effects include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Stomach pain
• Headache
• Fatigue
• Dizziness
• Indigestion
• Injection site reactions

Most gastrointestinal side effects improve as the body adjusts to treatment.

Important Safety Information

Wegovy is not appropriate for everyone. It should not be used by individuals with:

• A personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• A known allergy to semaglutide or any of its ingredients

Do not use Wegovy with other medications containing semaglutide or with another GLP-1 receptor agonist unless directed by a healthcare provider. Seek immediate medical attention if you experience severe abdominal pain, symptoms of pancreatitis, serious allergic reactions, or vision changes. (FDA Access Data)

Storage

Store unused Wegovy pens in a refrigerator at 36°F–46°F (2°C–8°C). Do not freeze. Follow the manufacturer’s storage instructions after first use and keep the medication protected from excessive heat and light. (FDA Access Data)

Disclaimer

Wegovy is a prescription-only medication and should only be used under the supervision of a licensed healthcare provider. Individual weight loss results vary. For best results, Wegovy should be used as part of a comprehensive weight management program that includes healthy eating, regular physical activity, and ongoing medical supervision.

Wegovy weight loss shots, Wegovy injection, semaglutide weight loss, weekly weight loss injection, GLP-1 weight loss medication, FDA-approved weight loss medication, prescription weight loss injection, chronic weight management, obesity treatment, semaglutide injections, appetite suppressant injection, medically supervised weight loss, prescription obesity medication, weight loss therapy, Wegovy for weight management.